Cases & Deals

  • Home
  • Practices
  • Delta Electronics acquires ACT Genomics from Prenetics Global Limited and other shareholders

Share

Delta Electronics acquires ACT Genomics from Prenetics Global Limited and other shareholders

October 2025

Client(s) Delta Electronics, Inc.

Jones Day advised Delta Electronics, Inc., a global leader in power management and smart green solutions, in its $71.78 million acquisition of ACT Genomics Holdings Company Limited from Prenetics Global Limited, a leading consumer health sciences company, and other shareholders. ACT Genomics provides next-generation sequencing (NGS), an advanced technology applied in oncology for early cancer detection, molecular diagnostics, treatment selection, and post-treatment monitoring, supporting a comprehensive approach to precision cancer care.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.